Triple antithrombotic therapy for atrial fibrillation and coronary stents

被引：0
|
作者：
Shmyr, Danielle [1 ]
Van der Merwe, Vanessa [2 ]
Yakiwchuk, Erin [2 ,3 ]
Barry, Arden [4 ,5 ]
Kosar, Lynette [6 ,7 ]
机构：
[1] Saskatoon Hlth Reg, Saskatoon, SK, Canada
[2] Saskatoon Hlth Reg, Geriatr Evaluat & Management Program, Saskatoon, SK, Canada
[3] Saskatoon Hlth Reg, Pharm Dept, Saskatoon, SK, Canada
[4] Chilliwack Gen Hosp, Lower Mainland Pharm Serv, Chilliwack, BC, Canada
[5] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada
[6] Saskatoon Hlth Reg, RxFiles Acad Detailing Program, Saskatoon, SK, Canada
[7] Univ Saskatchewan, Coll Pharm, Saskatoon, SK, Canada
来源：
CANADIAN FAMILY PHYSICIAN | 2017年 / 63卷 / 05期
关键词：
PROTON PUMP INHIBITORS; PERCUTANEOUS CORONARY; ANTIPLATELET THERAPY; FOCUSED UPDATE; CLOPIDOGREL; IMPLANTATION; MANAGEMENT; APIXABAN; DURATION; REGIMENS;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：375 / 381
页数：7
相关论文
共 50 条
  • [31] Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention
    Saito, Yuichi
    Kobayashi, Yoshio
    JOURNAL OF CARDIOLOGY, 2019, 73 (1-2) : 1 - 6
  • [32] Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting: Searching for the Best Combination
    Elewa, Hazem
    Ahmed, Dina
    Barnes, Geoffrey D.
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (06): : 662 - 670
  • [33] Comparison of triple antithrombotic therapy and dual antiplatelet therapy for patients with atrial fibrillation after percutaneous coronary stenting
    Fan, Xiaoying
    Zhang, Yao
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (05) : 1769 - 1773
  • [34] Outcomes of Rivaroxaban as Part of Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
    Alshahrani, Asma
    Alshareef, Hanan
    Alanazi, Zaid
    Alsawaq, Enas
    LATIN AMERICAN JOURNAL OF PHARMACY, 2022, 41 (05): : 917 - 922
  • [35] Acute Coronary Syndrome in Patients With Atrial Fibrillation What Is the Benefit/Risk Profile of Triple Antithrombotic Therapy?
    Maggioni, Aldo Pietro
    CIRCULATION, 2012, 126 (10) : 1176 - 1178
  • [36] Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faith
    Galli, Mattia
    Andreotti, Felicita
    D'Amario, Domenico
    Crea, Filippo
    Porto, Italo
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (03) : E16 - E17
  • [37] The antithrombotic therapy of atrial fibrillation in patients with coronary heart disease
    Bockeria, Olga L.
    Le, Tatyana G.
    RUSSIAN OPEN MEDICAL JOURNAL, 2018, 7 (04)
  • [38] Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
    Lili Wei
    Enyong Su
    Weili Liu
    Wenlu Xing
    Xinyun Liu
    You Zhang
    Shan Wang
    Qianqian Cheng
    Datun Qi
    Chuanyu Gao
    BMC Cardiovascular Disorders, 20
  • [39] Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome
    Bor, Wilbert
    Gorog, Diana A.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 14
  • [40] Antithrombotic therapy in coronary artery disease patients with atrial fibrillation
    Wei, Lili
    Su, Enyong
    Liu, Weili
    Xing, Wenlu
    Liu, Xinyun
    Zhang, You
    Wang, Shan
    Cheng, Qianqian
    Qi, Datun
    Gao, Chuanyu
    BMC CARDIOVASCULAR DISORDERS, 2020, 20 (01)
12345